1. Verhamme, KM, Dieleman, JP, Bleumink, GS, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care–the Triumph project. Eur Urol 2002; 42: 323–328.
Google Scholar | Crossref | Medline | ISI2. Kupelian, V, Wei, JT, O’Leary, MP, et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) survey. Arch Intern Med 2006; 166: 2381–2387.
Google Scholar | Crossref | Medline3. Parsons, JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep 2010; 5: 212–218.
Google Scholar | Crossref | Medline4. McVary, KT. BPH: epidemiology and comorbidities. Am J Manag Care 2006; 12(Suppl. 5): S122–S128.
Google Scholar | Medline5. Mancini, V, Balzarro, M, Illiano, E, et al. Lower urinary tract symptoms in elderly men: a simple yet comprehensive approach. J Clin Gerontol Geriatr 2018; 66: 245–252.
Google Scholar6. Rosen, RC. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia. Curr Opin Urol 2006; 16: 11–19.
Google Scholar | Crossref | Medline | ISI7. Oka, AAG, Duarsa, GWK, Novianti, PA, et al. The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia. Res Rep Urol 2019; 11: 91–96.
Google Scholar | Medline8. Bouhadana, D, Nguyen, DD, Zorn, KC, et al. Patient perspectives on benign prostatic hyperplasia surgery: a focus on sexual health. J Sex Med 2020; 17: 2108–2112.
Google Scholar | Crossref | Medline9. Jones, P, Rai, BP, Aboumarzouk, O, et al. UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia. Ther Adv Urol 2016; 8: 372–376.
Google Scholar | SAGE Journals | ISI10. Roehrborn, CG, Barkin, J, Gange, SN, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study . Can J Urol 2017; 24: 8802–8813.
Google Scholar | Medline11. Woo, HH, Bolton, DM, Laborde, E, et al. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med 2012; 9: 568–575.
Google Scholar | Crossref | Medline12. Gravas, S, Cornu, JN, Drake, MJ, et al. EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) 2018. European Association of Urology Guidelines 2018 ed. Arnhem, The Netherlands: European Association of Urology Guidelines Office, 2018.
Google Scholar13. Wollin, TA, Tieszer, C, Riddell, JV, et al. Bacterial biofilm formation, encrustation, and antibiotic adsorption to ureteral stents indwelling in humans. J Endourol 1998; 12: 101–111.
Google Scholar | Crossref | Medline | ISI14. Ng, BHS, Chung, E. A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatments for benign prostatic hyperplasia: impact on erectile and ejaculatory domains. Investig Clin Urol 2021; 62: 148–158.
Google Scholar | Crossref | Medline15. Ahyai, SA, Gilling, P, Kaplan, SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010; 58: 384–397.
Google Scholar | Crossref | Medline | ISI16. Reich, O, Gratzke, C, Bachmann, A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008; 180: 246–249.
Google Scholar | Crossref | Medline | ISI17. Eredics, K, Wachabauer, D, Rothlin, F, et al. Reoperation rates and mortality after transurethral and open prostatectomy in a long-term nationwide analysis: have we improved over a decade? Urology 2018; 118: 152–157.
Google Scholar | Crossref | Medline18. Rassweiler, J, Teber, D, Kuntz, R, et al. Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol 2006; 50: 969–979.
Google Scholar | Crossref | Medline | ISI19. Alloussi, SH, Lang, C, Eichel, R, et al. Ejaculation-preserving transurethral resection of prostate and bladder neck: short- and long-term results of a new innovative resection technique. J Endourol 2014; 28: 84–89.
Google Scholar | Crossref | Medline20. Wroclawski, ML, Teles, SB, Amaral, BS, et al. A systematic review and meta-analysis of the safety and efficacy of endoscopic enucleation and non-enucleation procedures for benign prostatic enlargement. World J Urol 2020; 38: 1663–1684.
Google Scholar | Crossref | Medline21. Cornu, JN, Ahyai, S, Bachmann, A, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 2015; 67: 1066–1096.
Google Scholar | Crossref | Medline22. Gratzke, C, Barber, N, Speakman, MJ, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int 2017; 119: 767–775.
Google Scholar | Crossref | Medline23. Sønksen, J, Barber, NJ, Speakman, MJ, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 2015; 68: 643–652.
Google Scholar | Crossref | Medline | ISI24. Roehrborn, CG. Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to Benign prostatic hyperplasia. Urol Clin North Am 2016; 43: 357–369.
Google Scholar | Crossref | Medline25. Roehrborn, CG, Rukstalis, DB, Barkin, J, et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 2015; 22: 7772–7782.
Google Scholar | Medline | ISI26. Zhang, SJ, Qian, HN, Zhao, Y, et al. Relationship between age and prostate size. Asian J Androl 2013; 15: 116–120.
Google Scholar | Crossref | Medline27. McVary, KT, Chughtai, B, Miller, LE, et al. Putting patients ahead by leaving nothing behind: an emerging treatment paradigm in minimally invasive surgical therapy for Benign prostatic hyperplasia. Med Devices (Auckl) 2021; 14: 59–64.
Google Scholar | Medline28. Miller, LE, Chughtai, B, Dornbier, RA, et al. Surgical reintervention rate after prostatic urethral lift: systematic review and meta-analysis involving over 2,000 patients. J Urol 2020; 204: 1019–1026.
Google Scholar | Crossref | Medline29. CChin, P, Robertson, P. Medium-term efficacy of the prostatic urethral lift. Transl Androl Urol 2017; 6(Suppl. 2): S122–S132.
Google Scholar30. Rukstalis, D, Grier, D, Stroup, SP, et al. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift study. Prostate Cancer Prostatic Dis 2019; 22: 411–419.
Google Scholar | Crossref | Medline